This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Growblox Sciences, Inc. announced that it had formed Growblox Life Sciences, LLC, a wholly-owned subsidiary, to pursue development of its intellectual property related to unique cannabis-based medical compounds.
The Company has retained Fenwick & West, a Silicon Valley based law firm focusing on life sciences and high technology companies with a nationally top-ranked intellectual property practice, to assist it in the development of strategies for the protection of the Company's intellectual property.
Growblox Life Sciences, LLC will be a research organization focused on scientific discoveries and applications. It will not commercially cultivate or sell cannabis. The Company believes that it has valuable and potentially patentable intellectual property for cannabis-based compounds that will treat a wide range of illnesses, including Parkinson's Disease.
Growblox CEO John Poss said, "I am very pleased that Fenwick & West has agreed to work with us on these important and potentially medically significant discoveries. They are clearly one of the leading intellectual property firms in the world. We know that if they agree to write patents on the fruits of our research and developments, then the patents will be defensible and potentially create great opportunities for commercial development."
